Longitudinal trends in blood pressure, prevalence, awareness, treatment, and control of hypertension in the Czech population. Are there any sex differences?
Czech MONICA
Czech post-MONICA study
epidemiology of hypertension
population random sample
response rate
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
31
08
2022
accepted:
28
10
2022
entrez:
28
11
2022
pubmed:
29
11
2022
medline:
29
11
2022
Statut:
epublish
Résumé
Hypertension is the most common cardiovascular disease which substantially increases cardiovascular morbidity and mortality. Despite the broad availability of antihypertensive medication, control of hypertension is not satisfactory worldwide. The study aim was to assess longitudinal trends in blood pressure, prevalence, awareness, treatment, and control of hypertension in a representative population sample of the Czechia from 1985 to 2016/2017, focusing on sex differences. A total of 7,606 men and 8,050 women aged 25-64 years were screened for major CV risk factors in seven independent cross-sectional surveys run consistently in the same six country districts of the Czechia between 1985 and 2016/2017. The population samples were randomly selected. Over a study period of 31/32 years, there was a significant decline in systolic and diastolic blood pressure in both sexes, whereas the prevalence of hypertension decreased only in women. There was an increase in hypertension awareness in both sexes over the entire study period with consistently higher rates in women. The proportion of individuals treated with antihypertensive drugs increased significantly in both sexes throughout the study, again with consistently higher rates in women. Control of hypertension increased significantly over the study period with consistently higher rates in women. The age-adjusted trends in blood pressure, prevalence, awareness, and treatment of hypertension were significantly different in men and women, always in favor of women. The age-adjusted trends in control of hypertension in treated patients were equally poor in both sexes. There are significant differences in longitudinal trends in blood pressure, prevalence, awareness, treatment, and control of hypertension between men and women, always in favor of women except for the control of hypertension in treated patients, where it is equally poor in both sexes.
Sections du résumé
Background
UNASSIGNED
Hypertension is the most common cardiovascular disease which substantially increases cardiovascular morbidity and mortality. Despite the broad availability of antihypertensive medication, control of hypertension is not satisfactory worldwide.
Objective
UNASSIGNED
The study aim was to assess longitudinal trends in blood pressure, prevalence, awareness, treatment, and control of hypertension in a representative population sample of the Czechia from 1985 to 2016/2017, focusing on sex differences.
Methods
UNASSIGNED
A total of 7,606 men and 8,050 women aged 25-64 years were screened for major CV risk factors in seven independent cross-sectional surveys run consistently in the same six country districts of the Czechia between 1985 and 2016/2017. The population samples were randomly selected.
Results
UNASSIGNED
Over a study period of 31/32 years, there was a significant decline in systolic and diastolic blood pressure in both sexes, whereas the prevalence of hypertension decreased only in women. There was an increase in hypertension awareness in both sexes over the entire study period with consistently higher rates in women. The proportion of individuals treated with antihypertensive drugs increased significantly in both sexes throughout the study, again with consistently higher rates in women. Control of hypertension increased significantly over the study period with consistently higher rates in women. The age-adjusted trends in blood pressure, prevalence, awareness, and treatment of hypertension were significantly different in men and women, always in favor of women. The age-adjusted trends in control of hypertension in treated patients were equally poor in both sexes.
Conclusion
UNASSIGNED
There are significant differences in longitudinal trends in blood pressure, prevalence, awareness, treatment, and control of hypertension between men and women, always in favor of women except for the control of hypertension in treated patients, where it is equally poor in both sexes.
Identifiants
pubmed: 36440040
doi: 10.3389/fcvm.2022.1033606
pmc: PMC9686845
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1033606Informations de copyright
Copyright © 2022 Cífková, Bruthans, Strilchuk, Wohlfahrt, Krajčoviechová, Šulc, Jozífová, Eremiášová, Pudil, Linhart, Widimský, Filipovský, Mayer, Škodová and Lánská.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur J Prev Cardiol. 2022 Feb 19;29(1):158-166
pubmed: 34056646
CMAJ. 2008 May 20;178(11):1441-9
pubmed: 18490640
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Int J Geriatr Psychiatry. 2011 Jul;26(7):661-9
pubmed: 21495075
Nat Rev Cardiol. 2021 Nov;18(11):785-802
pubmed: 34050340
Scand J Public Health. 2015 Mar;43(2):212-9
pubmed: 25592449
Lancet. 1999 May 8;353(9164):1547-57
pubmed: 10334252
Hypertension. 2017 Jun;69(6):1113-1120
pubmed: 28461599
PLoS One. 2020 May 11;15(5):e0232845
pubmed: 32392239
PLoS One. 2015 Oct 15;10(10):e0140461
pubmed: 26469176
J Nurs Res. 2020 Jun;28(3):e88
pubmed: 31904736
MMWR Morb Mortal Wkly Rep. 2017 Aug 18;66(32):846-849
pubmed: 28817553
BMC Cardiovasc Disord. 2008 Mar 17;8:6
pubmed: 18366642
Hypertension. 1995 Jul;26(1):60-9
pubmed: 7607734
Lancet. 2021 Sep 11;398(10304):957-980
pubmed: 34450083
Lancet. 2016 Mar 5;387(10022):957-967
pubmed: 26724178
BMC Public Health. 2015 Sep 24;15:957
pubmed: 26404853
Atherosclerosis. 2010 Aug;211(2):676-81
pubmed: 20471016
BMJ. 2009 May 19;338:b1665
pubmed: 19454737
BMC Cardiovasc Disord. 2012 Aug 31;12:68
pubmed: 22937997
Hypertension. 2017 Oct;70(4):736-742
pubmed: 28847890
CMAJ. 2011 Jun 14;183(9):1007-13
pubmed: 21576297
PLoS One. 2017 May 25;12(5):e0178334
pubmed: 28542557
Lancet. 2014 May 31;383(9932):1899-911
pubmed: 24881994
BMJ Open. 2020 Jul 8;10(7):e036418
pubmed: 32641331
Eur Heart J. 2020 Nov 7;41(42):4127-4137
pubmed: 33049774
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
J Hum Hypertens. 2015 Apr;29(4):247-53
pubmed: 25273858
JAMA. 2020 Sep 22;324(12):1190-1200
pubmed: 32902588
Eur J Epidemiol. 2005;20(11):887-98
pubmed: 16284866